Pulmonary arterial hypertension: promising advances and remaining challenges
- PMID: 34580122
- DOI: 10.1136/jim-2021-002152
Pulmonary arterial hypertension: promising advances and remaining challenges
Keywords: hypertension; pulmonary.
Conflict of interest statement
Competing interests: KE-K served on advisory boards for United Therapeutics and Actelion and as consultant for Acceleron Pharma, and received institutional funded research from United Therapeutics and Actelion.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources